- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04355559
The Value of Diaphragmatic Ultrasound in Non-invasive Oxygen Therapy
April 20, 2020 updated by: wang kaifei, Chinese PLA General Hospital
Department of Pulmonary & Critical Care Medicine, Chinese PLA General Hospital
In this study, a single-center, prospective, observational study was adopted to set the cut-off values of diaphragmatic ultrasound results and arterial blood gas results,with the choice of non-invasive oxygen therapy as the gold standard,so as to evaluate the diagnostic value of diaphragmatic ultrasound in the selection of non-invasive oxygen therapy.
Study Overview
Status
Unknown
Conditions
Detailed Description
- the cut-off values of diaphragmatic ultrasound results and arterial blood gas results were established by the selection results of non-invasive oxygen therapy of 120 patients in the intensive care unit and using receiver operating Characteristic curve.
diaphragm excursion,inspiratory time,diaphragm contraction velocity,diaphragm excursion time
Study Type
Observational
Enrollment (Anticipated)
120
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100853
- Recruiting
- Department of Pulmonary and Critical Care Medicine, Chinese PLA General Hospital
-
Contact:
- lixin xie, doctor
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
patients older than 18 years without Invasive mechanical ventilation when entering the intensive care unit.
Description
Inclusion Criteria:
- patients older than 18 years
- without Invasive mechanical ventilation when entering the intensive care unit.
Exclusion Criteria:
- have noninvasive ventilation or high flow nasal cannula contraindications
- history of neuromuscular disease chest wall deformities
- previously assessed diaphragmatic palsy
- shock or severe hemodynamic instability
- known pregnancy, and/or need for immediate endotracheal intubation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
conventional oxygen therapy
Continuous use of current oxygen therapy
|
high flow nasal cannula
change the oxygen therapy to high flow nasal cannula
|
Noninvasive ventilation
change the oxygen therapy to noninvasive ventilation
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the data diaphragmatic ultrasound
Time Frame: When the intervention which is the first time to change the oxygen therapy
|
Record the data at the baseline and intervention
|
When the intervention which is the first time to change the oxygen therapy
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Arterial blood gas analysis results
Time Frame: When the intervention which is the first time to change the oxygen therapy
|
Record the data at the baseline and intervention
|
When the intervention which is the first time to change the oxygen therapy
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
August 1, 2018
Primary Completion (Anticipated)
April 30, 2020
Study Completion (Anticipated)
August 31, 2020
Study Registration Dates
First Submitted
March 24, 2020
First Submitted That Met QC Criteria
April 20, 2020
First Posted (Actual)
April 21, 2020
Study Record Updates
Last Update Posted (Actual)
April 21, 2020
Last Update Submitted That Met QC Criteria
April 20, 2020
Last Verified
April 1, 2020
More Information
Terms related to this study
Other Study ID Numbers
- 2018TM-03
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Intensive Care Unit
-
University of MelbourneEnrolling by invitationICU Acquired Weakness | Intensive Care Unit Syndrome | Intensive Care Unit Acquired Weakness | Post Intensive Care Unit Syndrome | Post Intensive Care SyndromeAustralia
-
Seoul National University HospitalMinistry of Food and Drug Safety, KoreaCompletedPostoperative Care | Intensive Care UnitKorea, Republic of
-
Centre Hospitalier Régional d'OrléansRecruiting
-
Nantes University HospitalRecruiting
-
First People's Hospital of ChenzhouRecruiting
-
Hospira, now a wholly owned subsidiary of PfizerCompleted
-
Mayo ClinicCompletedPalliative Care | Intensive Care Unit | HospiceUnited States
-
Hospital Israelita Albert EinsteinActive, not recruitingCritical Care | Intensive Care UnitBrazil
-
Hospices Civils de LyonCompletedPediatric Intensive Care UnitFrance, Belgium, Lebanon, Switzerland
-
Taipei Veterans General Hospital, TaiwanCompletedIntensive Care Unit PatientsTaiwan